Two Sigma Securities’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Two Sigma Securities’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,101	Closed	-$10.6K	–	3833
2024 Q2	$10.6K	Buy	+16,101	New	+$10K	﹤0.01%	2800
2024 Q1	–	Sell	-24,574	Closed	-$14.4K	–	3811
2023 Q4	$14.4K	Buy	+24,574	New	+$14.8K	﹤0.01%	2771
2021 Q3	–	Sell	-549	Closed	-$55K	–	2047
2021 Q2	$55K	Buy	549 +162	+42%	+$15.8K	﹤0.01%	1390
2021 Q1	$36K	Buy	+387	New	+$39.2K	﹤0.01%	750
2020 Q2	–	Sell	-678	Closed	-$19K	–	1830
2020 Q1	$19K	Buy	+678	New	+$26.4K	﹤0.01%	1228
2019 Q4	–	Sell	-1,134	Closed	-$16K	–	2711
2019 Q3	$16K	Buy	1,134 +601	+113%	+$12.6K	﹤0.01%	1998
2019 Q2	$19K	Buy	+533	New	+$28.9K	﹤0.01%	1955

Two Sigma Securities's VBIV Position: Q3 2024 in Review

Two Sigma Securities sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 16,101 shares — an estimated $10.6K sold.

Two Sigma Securities first reported a position in VBIV in Q2 2019 and held it in 7 quarters. The position peaked at $55K in Q2 2021. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

Two Sigma Securities reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 16,101 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $10.6K.
Two Sigma Securities first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2019 and held it in 7 quarters.
Two Sigma Securities's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $55K in Q2 2021.
1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.